Nathanael Fillmore, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Veterans | 25 | 2024 | 2519 | 4.430 |
Why?
|
Venous Thromboembolism | 4 | 2023 | 1671 | 1.200 |
Why?
|
Multiple Myeloma | 7 | 2023 | 5181 | 1.080 |
Why?
|
Veterans Health | 6 | 2024 | 216 | 0.960 |
Why?
|
Disulfiram | 1 | 2021 | 57 | 0.800 |
Why?
|
Patient Identification Systems | 1 | 2020 | 79 | 0.740 |
Why?
|
Workflow | 3 | 2024 | 847 | 0.700 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2024 | 5221 | 0.670 |
Why?
|
Neoplasms | 9 | 2024 | 21683 | 0.660 |
Why?
|
Health Personnel | 2 | 2020 | 3218 | 0.570 |
Why?
|
Medical Informatics | 1 | 2024 | 745 | 0.570 |
Why?
|
Natural Language Processing | 2 | 2023 | 1041 | 0.540 |
Why?
|
Meningioma | 1 | 2024 | 1209 | 0.510 |
Why?
|
Hematologic Neoplasms | 2 | 2024 | 1832 | 0.490 |
Why?
|
United States Department of Veterans Affairs | 5 | 2022 | 875 | 0.490 |
Why?
|
Meningeal Neoplasms | 1 | 2024 | 1241 | 0.490 |
Why?
|
Occupational Health | 1 | 2020 | 809 | 0.470 |
Why?
|
Venous Thrombosis | 1 | 2023 | 1239 | 0.450 |
Why?
|
Cluster Analysis | 1 | 2020 | 2715 | 0.440 |
Why?
|
Lung Neoplasms | 5 | 2024 | 13102 | 0.430 |
Why?
|
Thrombosis | 2 | 2023 | 2968 | 0.410 |
Why?
|
Software | 3 | 2023 | 4443 | 0.410 |
Why?
|
United States | 18 | 2024 | 69872 | 0.360 |
Why?
|
Pulmonary Embolism | 1 | 2023 | 2376 | 0.360 |
Why?
|
Melanoma | 3 | 2023 | 5510 | 0.330 |
Why?
|
Glioblastoma | 1 | 2024 | 3481 | 0.320 |
Why?
|
Health Status Disparities | 1 | 2019 | 1797 | 0.300 |
Why?
|
Computer Simulation | 2 | 2020 | 6196 | 0.290 |
Why?
|
Humans | 56 | 2024 | 744343 | 0.290 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3086 | 0.290 |
Why?
|
Cohort Studies | 7 | 2023 | 40561 | 0.260 |
Why?
|
Medicare | 2 | 2022 | 6566 | 0.260 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5686 | 0.260 |
Why?
|
Retrospective Studies | 14 | 2024 | 77449 | 0.230 |
Why?
|
Plasma Cells | 2 | 2023 | 591 | 0.220 |
Why?
|
Aged | 15 | 2024 | 163280 | 0.220 |
Why?
|
Antirheumatic Agents | 2 | 2023 | 1339 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.210 |
Why?
|
Brain Neoplasms | 1 | 2024 | 8863 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.210 |
Why?
|
Allostasis | 1 | 2023 | 70 | 0.210 |
Why?
|
Spondylitis, Ankylosing | 1 | 2023 | 156 | 0.200 |
Why?
|
Hospitals, Veterans | 2 | 2022 | 404 | 0.200 |
Why?
|
Technology | 1 | 2024 | 305 | 0.200 |
Why?
|
Risk Factors | 10 | 2023 | 72290 | 0.190 |
Why?
|
Medical Records | 2 | 2023 | 1413 | 0.190 |
Why?
|
Platelet Function Tests | 1 | 2022 | 270 | 0.190 |
Why?
|
Delivery of Health Care | 3 | 2023 | 5319 | 0.190 |
Why?
|
Pancreatic Neoplasms | 3 | 2023 | 5256 | 0.190 |
Why?
|
Vaccination | 5 | 2023 | 3278 | 0.180 |
Why?
|
Medical Oncology | 3 | 2024 | 2265 | 0.180 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13695 | 0.180 |
Why?
|
Paraproteinemias | 1 | 2022 | 246 | 0.180 |
Why?
|
Algorithms | 5 | 2024 | 13881 | 0.170 |
Why?
|
Prognosis | 5 | 2023 | 29063 | 0.160 |
Why?
|
Systems Integration | 1 | 2020 | 440 | 0.160 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.150 |
Why?
|
Hematology | 1 | 2020 | 221 | 0.150 |
Why?
|
Arthritis, Rheumatoid | 2 | 2023 | 3712 | 0.150 |
Why?
|
Male | 15 | 2024 | 350118 | 0.140 |
Why?
|
Electronic Health Records | 3 | 2023 | 4468 | 0.140 |
Why?
|
Virus Diseases | 1 | 2022 | 711 | 0.140 |
Why?
|
International Classification of Diseases | 1 | 2021 | 867 | 0.130 |
Why?
|
Congresses as Topic | 1 | 2020 | 764 | 0.130 |
Why?
|
Psoriasis | 1 | 2023 | 898 | 0.130 |
Why?
|
Middle Aged | 9 | 2024 | 213383 | 0.130 |
Why?
|
Aged, 80 and over | 6 | 2023 | 57776 | 0.130 |
Why?
|
Tumor Burden | 1 | 2021 | 1915 | 0.130 |
Why?
|
Frail Elderly | 3 | 2023 | 693 | 0.120 |
Why?
|
Databases, Factual | 2 | 2019 | 7729 | 0.120 |
Why?
|
Learning | 1 | 2024 | 1713 | 0.120 |
Why?
|
Adult | 10 | 2024 | 214055 | 0.120 |
Why?
|
Pattern Recognition, Automated | 1 | 2020 | 1005 | 0.110 |
Why?
|
Monocytes | 1 | 2023 | 2596 | 0.110 |
Why?
|
Neoplasm Invasiveness | 1 | 2021 | 3616 | 0.110 |
Why?
|
ROC Curve | 1 | 2019 | 3527 | 0.100 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1772 | 0.100 |
Why?
|
Antiviral Agents | 4 | 2024 | 2987 | 0.100 |
Why?
|
Female | 10 | 2024 | 380194 | 0.100 |
Why?
|
Alcoholism | 1 | 2021 | 1906 | 0.100 |
Why?
|
Comorbidity | 2 | 2023 | 10388 | 0.090 |
Why?
|
Incidence | 3 | 2023 | 20947 | 0.090 |
Why?
|
Vitamin D Deficiency | 1 | 2020 | 1343 | 0.090 |
Why?
|
Prostatic Neoplasms | 2 | 2024 | 11124 | 0.090 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2425 | 0.080 |
Why?
|
Registries | 2 | 2022 | 8089 | 0.080 |
Why?
|
Mortality | 1 | 2019 | 2864 | 0.080 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3523 | 0.080 |
Why?
|
Boston | 1 | 2020 | 9313 | 0.080 |
Why?
|
Dementia | 1 | 2021 | 2518 | 0.070 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12354 | 0.070 |
Why?
|
Sequence Analysis, RNA | 1 | 2014 | 2012 | 0.070 |
Why?
|
Dexamethasone | 2 | 2023 | 1951 | 0.070 |
Why?
|
Geriatric Assessment | 2 | 2023 | 1372 | 0.070 |
Why?
|
Risk Assessment | 2 | 2023 | 23338 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 18370 | 0.060 |
Why?
|
Prevalence | 1 | 2021 | 15226 | 0.060 |
Why?
|
Pandemics | 2 | 2023 | 8388 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2022 | 6364 | 0.060 |
Why?
|
Prospective Studies | 3 | 2023 | 53288 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15540 | 0.060 |
Why?
|
Knowledge | 1 | 2024 | 181 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5137 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19905 | 0.050 |
Why?
|
Adenosine Diphosphate | 1 | 2022 | 425 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2022 | 8037 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 648 | 0.050 |
Why?
|
Eligibility Determination | 1 | 2024 | 403 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25043 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 634 | 0.040 |
Why?
|
Time Factors | 1 | 2021 | 40075 | 0.040 |
Why?
|
Platelet Aggregation | 1 | 2022 | 798 | 0.040 |
Why?
|
Adolescent | 2 | 2024 | 85781 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2022 | 7785 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39050 | 0.040 |
Why?
|
Attitude | 1 | 2023 | 776 | 0.040 |
Why?
|
Ambulatory Care Facilities | 1 | 2024 | 933 | 0.040 |
Why?
|
Young Adult | 1 | 2024 | 56430 | 0.040 |
Why?
|
Computer Security | 1 | 2019 | 262 | 0.040 |
Why?
|
Pancreatectomy | 1 | 2022 | 804 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15165 | 0.040 |
Why?
|
SEER Program | 1 | 2022 | 1508 | 0.040 |
Why?
|
Hemoglobins | 1 | 2023 | 1534 | 0.040 |
Why?
|
Healthcare Disparities | 2 | 2022 | 3158 | 0.040 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1071 | 0.030 |
Why?
|
Pancreas | 1 | 2022 | 1686 | 0.030 |
Why?
|
Propensity Score | 1 | 2021 | 1781 | 0.030 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2418 | 0.030 |
Why?
|
Anti-Inflammatory Agents | 1 | 2023 | 1790 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2043 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 11524 | 0.030 |
Why?
|
Hospitalization | 2 | 2022 | 10262 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2023 | 4420 | 0.030 |
Why?
|
Oxygen | 1 | 2022 | 4189 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2023 | 3586 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2214 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5535 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2022 | 13033 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8324 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 21746 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13989 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4445 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5720 | 0.020 |
Why?
|
Computational Biology | 1 | 2014 | 3521 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 12804 | 0.010 |
Why?
|
Mutation | 1 | 2024 | 29786 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9438 | 0.010 |
Why?
|
Animals | 1 | 2014 | 168757 | 0.000 |
Why?
|